Search Results - Jeffrey Vietri

Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan by Shigeki Nakamura, Masashi Mikami, Tomoyuki Hayamizu, Naohiro Yonemoto, Camille Moyon, Mark Gouldson, Catriona Crossan, Jeffrey Vietri, Kazumasa Kamei

Get full text

A benefit-cost analysis quantifying the broader socioeconomic value of adult respiratory vaccination programs in Japan by Claud Theakston, Matthew Napier, Simon Brassel, Kazumasa Kamei, Shuhei Ito, Jeffrey Vietri, Diana Mendes, Jingyan Yang, Tianyan Hu, Lotte Steuten

Get full text

The broader socio-economic value of adult respiratory disease vaccinations in the UK – results from a benefit cost analysis by Cale Harrison, Simon Brassel, Sulayman Chowdhury, Claud Theakston, Matthew Napier, Jeffrey Vietri, Diana Mendes, Jingyan Yang, Tianyan Hu, Lotte Steuten

Get full text

Uptake of Pneumococcal Vaccines Among U.S. Adults After 2022 Update to Recommendations by Ahuva Averin, MPP, Jeffrey Vietri, PhD, Adriano Arguedas Mohs, MD, Sarah J. Willis, PhD, MPH, Alexander Lonshteyn, PhD, Derek Weycker, PhD

Get full text

Disparities in invasive pneumococcal disease, pneumonia, and otitis media among US children by comorbidity profile and insurance status by Rotem Lapidot, Rotem Lapidot, Rotem Lapidot, Rotem Lapidot, Ahuva Averin, Derek Weycker, Liping Huang, Jeffrey Vietri, Adriano Arguedas, Alejandro Cane, Alexander Lonshteyn, Mark H. Rozenbaum, Stephen I. Pelton, Stephen I. Pelton

Get full text